Singapore Paincare Holdings Limited (SGX:FRQ)
0.1590
+0.0020 (1.27%)
At close: Aug 12, 2025
Orchard Therapeutics Revenue
Singapore Paincare Holdings had revenue of 14.20M SGD in the half year ending December 31, 2024, with 27.70% growth. This brings the company's revenue in the last twelve months to 28.24M, up 14.14% year-over-year. In the fiscal year ending June 30, 2024, Singapore Paincare Holdings had annual revenue of 27.49M with 22.58% growth.
Revenue (ttm)
28.24M
Revenue Growth
+14.14%
P/S Ratio
0.95
Revenue / Employee
268.99K
Employees
105
Market Cap
26.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 27.49M | 5.06M | 22.58% |
Jun 30, 2023 | 22.42M | 3.23M | 16.85% |
Jun 30, 2022 | 19.19M | 7.84M | 69.05% |
Jun 30, 2021 | 11.35M | 1.38M | 13.82% |
Jun 30, 2020 | 9.97M | 5.99M | 150.57% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DBS Group Holdings | 22.10B |
Oversea-Chinese Banking Corporation | 13.72B |
Singapore Telecommunications | 14.15B |
United Overseas Bank | 13.32B |
Singapore Technologies Engineering | 11.28B |
Jardine Matheson Holdings | 45.30B |
Singapore Airlines | 19.54B |
Wilmar International | 91.96B |